Pro-life CEO predicts Trump FDA nominee could bring renewed scrutiny to abortion drug risks
Trump's FDA nominee Heidi Overton could bring renewed scrutiny to mifepristone, says Americans United for Life CEO who calls her a "pro-life" pick.
Trump's FDA nominee Heidi Overton could bring renewed scrutiny to mifepristone, says Americans United for Life CEO who calls her a "pro-life" pick.
Read the full article on Fox News
Read Full Article →